Portfolio

Our Investment in MiLaboratories: revolutionizing genomic data analysis for biologists

Our Investment in XRF: paving the way for AI and defense innovation

Our investment Skillvue: revolutionizing skills assessment with AI for candidates and employees

Exoticca secures €60 million in Series D funding to accelerate growth

IMU Biosciences raises £11.5 million in Series A funding to revolutionise immune powered precision medicine

Our investment in Trebellar: on a mission to make buildings smarter

Stylitics acquires our portfolio company Wide Eyes, the advanced visual AI solutions startup for fashion and retail

Our investment in Crescenta: democratizing access to private markets

Okta acquires Arengu